Isofol Receives Clinical Use Patent Approval in the United States for Drug Candidate arfolitixorin PRNewswire
GOTHENBURG, Sweden, June 25, 2019 /PRNewswire/ — Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced approval of a …